• Western blot analysis of extracts of various cell lines, using MATN3 antibody (STJ110013) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.

Anti-MATN3 antibody (277-486) (STJ110013)

SKU:
STJ110013

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-MATN3 (277-486) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MATN3
Gene ID: 4148
Uniprot ID: MATN3_HUMAN
Immunogen Region: 277-486
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 277-486 of human MATN3 (NP_002372.1).
Immunogen Sequence: HVCISDGEGKHHCECSQGYT LNADKKTCSALDRCALNTHG CEHICVNDRSGSYHCECYEG YTLNEDRKTCSAQDKCALGT HGCQHICVNDRTGSHHCECY EGYTLNADKKTCSVRDKCAL GSHGCQHICVSDGAASYHCD CYPGYTLNEDKKTCSATEEA RRLVSTEDACGCEATLAFQD KVSSYLQRLNTKLDDILEKL KINEYGQIHR
Tissue Specificity Expressed only in cartilaginous tissues, such as vertebrae, ribs and shoulders.
Function Major component of the extracellular matrix of cartilage and may play a role in the formation of extracellular filamentous networks.
Protein Name Matrilin-3
Database Links Reactome: R-HSA-3000178
Reactome: R-HSA-381426
Reactome: R-HSA-8957275
Cellular Localisation Secreted
Alternative Antibody Names Anti-Matrilin-3 antibody
Anti-MATN3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance